<DOC>
	<DOCNO>NCT02788383</DOCNO>
	<brief_summary>Actually , center prenatal determination RhD fetal genotype RhD negative pregnant woman . The investigator want demonstrate useful efficient method .</brief_summary>
	<brief_title>Fetal RhD Genotye Non Invasive Prenatal Determination</brief_title>
	<detailed_description>This retrospective observational study pretend demonstrate prenatal determination RhD fetal genotype useful efficient clinical practice . I 'm go check clinical history negative RhD pregnant woman since January 2013 December 2015 . I 'll check prenatal determination match postnatal RhD determination newborn . Usually , RhD negative woman pregnant administrate gammaglobulin 28 gestation week , invasive procedure delivery baby positive RhD . Althought , investigator know 40 percent RhD negative pregnant negative RhD baby . This study posible know many gammaglobulins n't necessary thanks prenatal determination . This important thing gammaglobulin humanoid product ( n't without heatlth risk , ... ) expensive . For reason , investigator universal determination RhD fetal genotype investigator avoid administration humanoid product pregnant woman . I want demonstrate practice useful efficient population .</detailed_description>
	<criteria>Pregnant RhD negative woman Pregnant RhD positive woman</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>